Cost-effectiveness perspectives in coronary heart disease.
作者： Lee Goldman
DOI: 10.1016/S0002-8703(05)80054-7
关键词:
摘要: In the United States there has been a dramatic decrease in age-adusted coronary heart disease (CHD) mortality during last 20 years. This article investigates reasons for this decline and concludes that most of CHD result life-style changes, particularly reduction serum cholesterol cigarette smoking. The Policy Model is used to compare effect targeted versus population-wide program reduction. On basis these projections, interventions are considered an important part programs. also assesses cost-effectiveness selected cardiac interventions, example, screening exercise tolerance tests, care units, thrombolysis acute myocardial infarction, β-blockers patients after infarction. Cost-effectiveness analysis seen be crucial as medical costs escalate population at risk from increases
elsevier.com
sci-hub.se 参考文章(23)
K M Detre, T Takaro, M J Lipton, H N Hultgren, The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation. ,vol. 54, ,(1976)
L Goldman, F Cook, B Hashimotso, P Stone, J Muller, A Loscalzo, Evidence that hospital care for acute myocardial infarction has not contributed to the decline in coronary mortality between 1973-1974 and 1978-1979. Circulation. ,vol. 65, pp. 936- 942 ,(1982) , 10.1161/01.CIR.65.5.936
G Bonadonna, S Monfardini, AlbertoM Marmont, E Damasio, F Rossi, Cardiac toxicity of daunorubicin. The Lancet. ,vol. 1, pp. 837- 838 ,(1969) , 10.1016/S0140-6736(69)92093-5
Alan J. Tiefenbrunn, Coronary Thrombolysis— It's Worth the Risk JAMA: The Journal of the American Medical Association. ,vol. 261, pp. 2107- 2108 ,(1989) , 10.1001/JAMA.1989.03420140109036
L Goldman, M C Weinstein, L W Williams, Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Projections of the Coronary Heart Disease Policy Model. Circulation. ,vol. 80, pp. 254- 260 ,(1989) , 10.1161/01.CIR.80.2.254
Gary D. Friedman, Diana B. Petitti, Richard D. Bawol, A. B. Siegelaub, Mortality in cigarette smokers and quitters. Effect of base-line differences. The New England Journal of Medicine. ,vol. 304, pp. 1407- 1410 ,(1981) , 10.1056/NEJM198106043042308
Christopher G. Isles, Louise M. Walker, Gareth D. Beevers, Irene Brown, Helen L. Cameron, John Clarke, Victor Hawthorne, David Hole, Anthony F. Lever, James W.K. Robertson, Jean A. Wapshaw, Mortality in patients of the Glasgow Blood Pressure Clinic. Journal of Hypertension. ,vol. 4, pp. 141- 156 ,(1986) , 10.1097/00004872-198604000-00003
J.D. Hill, J.R. Hampton, J.R.A. Mitchell, A RANDOMISED TRIAL OF HOME-VERSUS-HOSPITAL MANAGEMENT FOR PATIENTS WITH SUSPECTED MYOCARDIAL INFARCTION The Lancet. ,vol. 311, pp. 837- 841 ,(1978) , 10.1016/S0140-6736(78)90190-3
LEE GOLDMAN, The Decline in Ischemic Heart Disease Mortality Rates Annals of Internal Medicine. ,vol. 101, pp. 825- 836 ,(1984) , 10.7326/0003-4819-101-6-825
Harvey V. Fineberg, David Scadden, Lee Goldman, Care of Patients with a Low Probability of Acute Myocardial Infarction New England Journal of Medicine. ,vol. 310, pp. 1301- 1307 ,(1984) , 10.1056/NEJM198405173102006